drugset / Trial / NCT00674687

A Study Of The Efficacy Of Gabapentin In Neuropathic Pain Patients As Measured By Quantitative Sensory Testing

NCT00674687

Completed 23 enrolled Viatris Inc.
RandomizedCrossoverTriple-blindTreatment

Summary

The purpose of this study is to assess the reproducibility and the effect of gabapentin on quantitative sensory testing assessments in neuropathic pain subjects.

Timeline

Start
2004-07
Primary completion
Completion
2006-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Gabapentin Small molecule 600 mg Oral